Dec. 19, 2023 |
|
April. 02, 2024 |
|
jRCT1032230520 |
An Uncontrolled, Open-label, Exploratory Trial Investigating Temporal Changes in Microcirculatory Dysfunction in Patients with Takotsubo Syndrome Using Pressurewire X |
|
evaluation of microvascular dysfunction in patients with Takotsubo syndrome |
Ken Kato |
||
Chiba University Hospital |
||
1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba 260-86 77, JAPAN |
||
+81-43-222-7171 |
||
caua3419@chiba-u.jp |
||
Hiroki Goto |
||
Chiba University Hospital |
||
1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba 260-86 77, JAPAN |
||
+81-43-222-7171 |
||
cdca0048@chiba-u.jp |
Recruiting |
Dec. 19, 2023 |
||
12 | ||
Interventional |
||
single arm study |
||
open(masking not used) |
||
uncontrolled control |
||
single assignment |
||
diagnostic purpose |
||
This clinical trial sets two stages of selection criteria, primary registration and secondary registration, and targets patients who meet all the criteria at each stage. Primary registration is conducted for patients suspected of having Takotsubo syndrome. Secondary registration is conducted after catheter examination. |
||
Patients conflicting with any of the following will not be included in this clinical trial: |
||
18age old over | ||
No limit | ||
Both |
||
takotsubo syndrome |
||
To evaluate coronary artery microcirculatory resistance and coronary flow reserve changes during th |
||
takotsubo syndrome,Microvascular Angina,Coronary spasm angina |
||
D054549 |
||
Changes over time (acute phase - after 3 months) in microvascular resistance index by pressurewireX (Abbott) |
||
Changes over time (acute phase - after 3 months)in coronary flow reserve obtained by pressurewireX (Abbott), and the ratio of lactate levels of blood obtained from coronary |
Clinical Research Initiation-Fund of Chiba University Hospital | |
Applicable |
Chiba University Certified Clinical Research Review Board | |
1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba 260-8677, JAPAN , Chiba, Chiba | |
+81-43-226-2616 |
|
prc-jim@chiba-u.jp | |
Approval | |
Dec. 01, 2023 |
No |
|
none |